Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes
Open Access
- 29 September 2017
- journal article
- research article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 24 (2), 386-392
- https://doi.org/10.1016/j.bbmt.2017.09.016
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL084054, HL122173, T32HL007093, and HL088021)
- National Cancer Institute (CA18029, CA15704, CA078902)
This publication has 23 references indexed in Scilit:
- The effect of long-term ruxolitinib treatment on JAK2p.V617F allele burden in patients with myelofibrosisBlood, 2015
- The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantationPublished by American Society of Hematology ,2012
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for MyelofibrosisNew England Journal of Medicine, 2012
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for MyelofibrosisNew England Journal of Medicine, 2012
- DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion StatusJournal of Clinical Oncology, 2011
- A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)Blood, 2010
- International Prognostic Scoring System–independent cytogenetic risk categorization in primary myelofibrosisBlood, 2010
- Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia MyelofibrosisJournal of Clinical Oncology, 2009
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changesBlood, 2009
- Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosisBlood, 2001